Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
This study has been terminated.
(Due to the achievement of minimum required sample size and new changes in local regulations.)
Sponsor:
Janssen-Cilag, S.A.
Information provided by:
Janssen-Cilag, S.A.
ClinicalTrials.gov Identifier:
NCT00511628
First received: August 2, 2007
Last updated: May 18, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | January 2003 |
| Estimated Primary Completion Date: | No date given |